Detalhe da pesquisa
1.
Trial of Cinpanemab in Early Parkinson's Disease.
N Engl J Med
; 387(5): 408-420, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921450
2.
Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable Sensors.
Sensors (Basel)
; 22(18)2022 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146181
3.
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
Ann Neurol
; 88(3): 574-587, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542885
4.
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
Mov Disord
; 36(12): 2945-2950, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480363
5.
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
BMC Neurol
; 21(1): 459, 2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34814867
6.
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
Ann Neurol
; 85(6): 801-811, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30973966
7.
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
Ann Neurol
; 85(2): 259-271, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30549331
8.
Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.
Acta Neuropathol
; 140(5): 675-693, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804255
9.
Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up.
Mov Disord
; 35(9): 1550-1557, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657461
10.
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?
Mov Disord
; 35(9): 1618-1625, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32520435
11.
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
Mov Disord
; 35(11): 1999-2008, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798333
12.
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
Mov Disord
; 35(5): 833-844, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073681
13.
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
PLoS Med
; 16(10): e1002931, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31603904
14.
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
Mov Disord
; 34(9): 1354-1364, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31361367
15.
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
Brain
; 141(7): 2181-2193, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29878075
16.
18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.
Ann Neurol
; 82(4): 622-634, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28980714
17.
Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials.
Mov Disord
; 33(4): 528-536, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624752
18.
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.
Mov Disord
; 33(5): 771-782, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572948
19.
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Brain
; 140(3): 748-763, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077397
20.
Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.
Eur J Nucl Med Mol Imaging
; 44(5): 825-837, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28064343